Avitas Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-85,556
| Closed | -$2.48M | – | 200 |
|
|
2024
Q3 | $2.48M | Buy |
85,556
+1,403
| +2% | +$40.6K | 0.35% | 76 |
|
|
2024
Q2 | $2.35M | Buy |
84,153
+20,001
| +31% | +$560K | 0.34% | 76 |
|
|
2024
Q1 | $1.78M | Buy |
+64,152
| New | +$1.78M | 0.27% | 99 |
|
|
2023
Q4 | – | Sell |
-81,997
| Closed | -$2.72M | – | 206 |
|
|
2023
Q3 | $2.72M | Sell |
81,997
-22,017
| -21% | -$730K | 0.52% | 52 |
|
|
2023
Q2 | $3.82M | Buy |
104,014
+24,462
| +31% | +$897K | 0.69% | 39 |
|
|
2023
Q1 | $3.25M | Sell |
79,552
-916
| -1% | -$37.4K | 0.64% | 45 |
|
|
2022
Q4 | $4.12M | Sell |
80,468
-1,268
| -2% | -$65K | 0.87% | 36 |
|
|
2022
Q3 | $3.58M | Buy |
81,736
+1,321
| +2% | +$57.8K | 0.82% | 34 |
|
|
2022
Q2 | $4.22M | Buy |
80,415
+1,185
| +1% | +$62.1K | 0.92% | 28 |
|
|
2022
Q1 | $4.1M | Sell |
79,230
-37,765
| -32% | -$1.96M | 0.74% | 33 |
|
|
2021
Q4 | $6.91M | Buy |
116,995
+25,571
| +28% | +$1.51M | 1.16% | 22 |
|
|
2021
Q3 | $3.93M | Sell |
91,424
-320
| -0.3% | -$13.8K | 0.72% | 54 |
|
|
2021
Q2 | $3.59M | Buy |
91,744
+2,595
| +3% | +$102K | 0.64% | 59 |
|
|
2021
Q1 | $3.23M | Buy |
89,149
+20,940
| +31% | +$759K | 0.63% | 57 |
|
|
2020
Q4 | $2.51M | Buy |
68,209
+22,049
| +48% | +$812K | 0.51% | 78 |
|
|
2020
Q3 | $1.61M | Buy |
+46,160
| New | +$1.61M | 0.45% | 89 |
|